311 related articles for article (PubMed ID: 23737552)
1. The deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling.
Garg AV; Ahmed M; Vallejo AN; Ma A; Gaffen SL
Sci Signal; 2013 Jun; 6(278):ra44. PubMed ID: 23737552
[TBL] [Abstract][Full Text] [Related]
2. Proinflammatory mediators alter expression of nuclear factor kappa B-regulating deubiquitinases in sinonasal epithelial cells.
Li P; Wang Y; Turner JH
Int Forum Allergy Rhinol; 2015 Jul; 5(7):583-9. PubMed ID: 25907801
[TBL] [Abstract][Full Text] [Related]
3. SEF/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction.
Onishi RM; Park SJ; Hanel W; Ho AW; Maitra A; Gaffen SL
J Biol Chem; 2010 Oct; 285(43):32751-32759. PubMed ID: 20729198
[TBL] [Abstract][Full Text] [Related]
4. Expression, biological activities and mechanisms of action of A20 (TNFAIP3).
Verstrepen L; Verhelst K; van Loo G; Carpentier I; Ley SC; Beyaert R
Biochem Pharmacol; 2010 Dec; 80(12):2009-20. PubMed ID: 20599425
[TBL] [Abstract][Full Text] [Related]
5. Histone methyltransferase Ash1l suppresses interleukin-6 production and inflammatory autoimmune diseases by inducing the ubiquitin-editing enzyme A20.
Xia M; Liu J; Wu X; Liu S; Li G; Han C; Song L; Li Z; Wang Q; Wang J; Xu T; Cao X
Immunity; 2013 Sep; 39(3):470-81. PubMed ID: 24012418
[TBL] [Abstract][Full Text] [Related]
6. The deubiquitinase activity of A20 is dispensable for NF-κB signaling.
De A; Dainichi T; Rathinam CV; Ghosh S
EMBO Rep; 2014 Jul; 15(7):775-83. PubMed ID: 24878851
[TBL] [Abstract][Full Text] [Related]
7. The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-kappaB activation at the level of TRAF6.
Heyninck K; Beyaert R
FEBS Lett; 1999 Jan; 442(2-3):147-50. PubMed ID: 9928991
[TBL] [Abstract][Full Text] [Related]
8. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease.
Zhou Q; Wang H; Schwartz DM; Stoffels M; Park YH; Zhang Y; Yang D; Demirkaya E; Takeuchi M; Tsai WL; Lyons JJ; Yu X; Ouyang C; Chen C; Chin DT; Zaal K; Chandrasekharappa SC; Hanson EP; Yu Z; Mullikin JC; Hasni SA; Wertz IE; Ombrello AK; Stone DL; Hoffmann P; Jones A; Barham BK; Leavis HL; van Royen-Kerkof A; Sibley C; Batu ED; Gül A; Siegel RM; Boehm M; Milner JD; Ozen S; Gadina M; Chae J; Laxer RM; Kastner DL; Aksentijevich I
Nat Genet; 2016 Jan; 48(1):67-73. PubMed ID: 26642243
[TBL] [Abstract][Full Text] [Related]
9. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
Heyninck K; De Valck D; Vanden Berghe W; Van Criekinge W; Contreras R; Fiers W; Haegeman G; Beyaert R
J Cell Biol; 1999 Jun; 145(7):1471-82. PubMed ID: 10385526
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
[TBL] [Abstract][Full Text] [Related]
11. A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling.
Gui J; Yue Y; Chen R; Xu W; Xiong S
PLoS One; 2012; 7(9):e46515. PubMed ID: 23029542
[TBL] [Abstract][Full Text] [Related]
12. Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling.
Shembade N; Harhaj NS; Liebl DJ; Harhaj EW
EMBO J; 2007 Sep; 26(17):3910-22. PubMed ID: 17703191
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection.
Liuwantara D; Elliot M; Smith MW; Yam AO; Walters SN; Marino E; McShea A; Grey ST
Diabetes; 2006 Sep; 55(9):2491-501. PubMed ID: 16936197
[TBL] [Abstract][Full Text] [Related]
14. The anaphase-promoting complex protein 5 (AnapC5) associates with A20 and inhibits IL-17-mediated signal transduction.
Ho AW; Garg AV; Monin L; Simpson-Abelson MR; Kinner L; Gaffen SL
PLoS One; 2013; 8(7):e70168. PubMed ID: 23922952
[TBL] [Abstract][Full Text] [Related]
15. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction.
Schwandner R; Yamaguchi K; Cao Z
J Exp Med; 2000 Apr; 191(7):1233-40. PubMed ID: 10748240
[TBL] [Abstract][Full Text] [Related]
16. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.
Wertz IE; O'Rourke KM; Zhou H; Eby M; Aravind L; Seshagiri S; Wu P; Wiesmann C; Baker R; Boone DL; Ma A; Koonin EV; Dixit VM
Nature; 2004 Aug; 430(7000):694-9. PubMed ID: 15258597
[TBL] [Abstract][Full Text] [Related]
17. IL-17R activation of human periodontal ligament fibroblasts induces IL-23 p19 production: Differential involvement of NF-κB versus JNK/AP-1 pathways.
Zhu L; Wu Y; Wei H; Xing X; Zhan N; Xiong H; Peng B
Mol Immunol; 2011 Jan; 48(4):647-56. PubMed ID: 21145111
[TBL] [Abstract][Full Text] [Related]
18. TRAF Family Member-associated NF-κB Activator (TANK) Inhibits Genotoxic Nuclear Factor κB Activation by Facilitating Deubiquitinase USP10-dependent Deubiquitination of TRAF6 Ligase.
Wang W; Huang X; Xin HB; Fu M; Xue A; Wu ZH
J Biol Chem; 2015 May; 290(21):13372-85. PubMed ID: 25861989
[TBL] [Abstract][Full Text] [Related]
19. A20 ameliorates inflammatory bowel disease in mice via inhibiting NF-κB and STAT3 activation.
Lee SH; Lee HR; Kwon JY; Jung K; Kim SY; Cho KH; Choi J; Lee HH; Lee BI; Jue DM; Cho ML
Immunol Lett; 2018 Jun; 198():44-51. PubMed ID: 29608924
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-17F signaling requires ubiquitination of interleukin-17 receptor via TRAF6.
Rong Z; Cheng L; Ren Y; Li Z; Li Y; Li X; Li H; Fu XY; Chang Z
Cell Signal; 2007 Jul; 19(7):1514-20. PubMed ID: 17346928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
